Ror2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression
Open Access
- 26 June 2017
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 36 (43) , 5958-5968
Abstract
Cellular heterogeneity is a common feature in breast cancer, yet an understanding of the coexistence and regulation of various tumor cell subpopulations remains a significant challenge in cancer biology. In the current study, we approached tumor cell heterogeneity from the perspective of Wnt pathway biology to address how different modes of Wnt signaling shape the behaviors of diverse cell populations within a heterogeneous tumor landscape. Using a syngeneic TP53-null mouse model of breast cancer, we identified distinctions in the topology of canonical Wnt β-catenin-dependent signaling activity and non-canonical β-catenin-independent Ror2-mediated Wnt signaling across subtypes and within tumor cell subpopulations in vivo. We further discovered an antagonistic role for Ror2 in regulating canonical Wnt/β-catenin activity in vivo, where lentiviral shRNA depletion of Ror2 expression augmented canonical Wnt/β-catenin signaling activity across multiple basal-like models. Depletion of Ror2 expression yielded distinct phenotypic outcomes and divergent alterations in gene expression programs among different tumors, despite all sharing basal-like features. Notably, we uncovered cell state plasticity and adhesion dynamics regulated by Ror2, which influenced Ras Homology Family Member A (RhoA) and Rho-Associated Coiled-Coil Kinase 1 (ROCK1) activity downstream of Dishevelled-2 (Dvl2). Collectively, these studies illustrate the integration and collaboration of Wnt pathways in basal-like breast cancer, where Ror2 provides a spatiotemporal function to regulate the balance of Wnt signaling and cellular heterogeneity during tumor progression.Keywords
This publication has 76 references indexed in Scilit:
- Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypesBreast Cancer Research and Treatment, 2013
- Ezrin, Radixin and Moesin: key regulators of membrane–cortex interactions and signalingCurrent Opinion in Cell Biology, 2011
- β-Catenin Dosage Is a Critical Determinant of Tracheal Basal Cell Fate DeterminationThe American Journal of Pathology, 2011
- Wnt Signaling Gradients Establish Planar Cell Polarity by Inducing Vangl2 Phosphorylation through Ror2Developmental Cell, 2011
- Deconstructing the molecular portraits of breast cancerMolecular Oncology, 2010
- Organizing the cell cortex: the role of ERM proteinsNature Reviews Molecular Cell Biology, 2010
- Selective targeting of radiation-resistant tumor-initiating cellsProceedings of the National Academy of Sciences, 2010
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating featuresProceedings of the National Academy of Sciences, 2009
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences, 2001